South Korea - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, South Korea Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry rose 6.9% year on year. In 2019, the country was ranked number 7 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $1,800,532,171.69 Million PPP. South Korea is overtaken by Belgium, which was number 6 with $3,043,879,424.39 Million PPP and is followed by Denmark at $1,510,421,981.56 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, +3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 1,800,532,171.69 |
| 2018 | 1,729,856,805.62 |
| 2017 | 1,657,739,085.13 |
| 2016 | 1,584,149,574.43 |
| 2015 | 1,576,441,459.10 |
How does South Korea rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 6 |
#6
Belgium
|
3,043,879,424.39 | 2019 | +4.4 % | +9.3 % | View data | |
| 7 |
#7
South Korea
|
1,800,532,171.69 | 2019 | +4.1 % | +6.9 % | View data | |
| 8 |
#8
Denmark
|
1,510,421,981.56 | 2019 | +2.8 % | +5.4 % | View data | |